ag 1879 has been researched along with buparvaquone in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Angelisová, P; Baumgartner, M; Horejsí, V; Langsley, G; Mooney, N; Setterblad, N; Werling, D | 1 |
1 other study(ies) available for ag 1879 and buparvaquone
Article | Year |
---|---|
Constitutive exclusion of Csk from Hck-positive membrane microdomains permits Src kinase-dependent proliferation of Theileria-transformed B lymphocytes.
Topics: Animals; Antiprotozoal Agents; B-Lymphocytes; Cattle; Cell Division; Cell Transformation, Neoplastic; CSK Tyrosine-Protein Kinase; Enzyme Activation; Enzyme Inhibitors; Lymphocyte Activation; Membrane Microdomains; Membrane Proteins; Naphthoquinones; Phenotype; Phosphatidylinositol 3-Kinases; Phosphoproteins; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-hck; Pyrimidines; Signal Transduction; src-Family Kinases; Theileria parva; Transcription Factor AP-1 | 2003 |